WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 594 participants.

Also called NCT04701684

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 594 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04701684
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Argentina, Belgium, Brazil, France, Germany, Netherlands, Romania, Spain, Türkiye (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT04701684. Randomized; no masking; primary purpose diagnostic. Start 2021-06-23 (actual); primary completion 2027-04-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)
Condition
Stroke, Acute
Intervention (Device)
Direct to Angio Suite (DTAS) Philips' CBCT triage
Intervention (Procedure)
Conventional CT/MR triage
Lead sponsor
Philips Clinical & Medical Affairs Global (class: industry)

Record details

Record id
cardio:ct-nct04701684
Content hash
cdf0912d8daf8092d27bc07dd30d3deea33a6d3620f8d5328924ebd4c74a61df